rokitamycin

Known as: pro-leucomycin A5, 3''-O-propionylleucomycin A5, TMS-19-Q 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The present study demonstrates the in vitro effectiveness of the macrolide rokitamycin and the phenothiazine compound… (More)
Is this relevant?
2002
2002
This study aimed to evaluate the bactericidal rates of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against… (More)
  • table 1
  • figure 1
Is this relevant?
2001
2001
Laboratory differentiation of erythromycin resistance phenotypes is poorly standardized for pneumococci. In this study, 85… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
Is this relevant?
2000
2000
In the present study we showed by molecular analysis that the inhibition of motility by macrolides in Proteus mirabilis and… (More)
Is this relevant?
2000
2000
The subinhibitory and suprainhibitory concentrations of many antibiotics are capable of interfering with the morphology of… (More)
Is this relevant?
Review
1993
Review
1993
After the discovery of erythromycin and other natural compounds, including oleandomycin, spiramycin, josamycin and midecamycin… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
The purpose of this study was to clarify the antibacterial efficacy of mixed antibacterial drugs on bacteria of carious and… (More)
Is this relevant?
Review
1992
Review
1992
The macrolide antibiotics include natural members, prodrugs and semisynthetic derivatives. These drugs are indicated in a variety… (More)
Is this relevant?
1990
1990
Rokitamycin (RKM), a 3"-O-propionyl derivative of leucomycin A5, is bactericidal against staphylococci near the minimum… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The in vitro activities of several 14-, 15- and 16-membered macrolides were compared with that of erythromycin. In general, 14… (More)
Is this relevant?